← Back to Search

Anti-metabolites

ADX-2191 (intravitreal methotrexate 0.8%) for Proliferative Vitreoretinopathy

Phase 3
Waitlist Available
Research Sponsored by Aldeyra Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Pivotal Trial

Summary

This trial tests a treatment called ADX-2191 to prevent a serious eye condition that can lead to vision loss. It targets patients who are at risk of developing this condition by stopping the growth of scar tissue inside the eye.

Eligible Conditions
  • Proliferative Vitreoretinopathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ADX-2191 (intravitreal methotrexate 0.8%)Experimental Treatment1 Intervention
ADX-2191 (intravitreal methotrexate 0.8%) administered over 16 weeks.
Group II: Standard surgical care procedureActive Control1 Intervention
Standard procedure performed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADX-2191 (intravitreal methotrexate 0.8%)
2019
Completed Phase 3
~110

Find a Location

Who is running the clinical trial?

Aldeyra Therapeutics, Inc.Lead Sponsor
33 Previous Clinical Trials
4,572 Total Patients Enrolled
~18 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top